New dental paste to treat oral lesions comes to market

Kourzeq (triamcinolone acetonide dental paste USP, 0.1%). Image courtesy of MidAmerica Pharmaceuticals and BeyondMD.
Kourzeq (triamcinolone acetonide dental paste USP, 0.1%). Image courtesy of MidAmerica Pharmaceuticals and BeyondMD.

MidAmerica Pharmaceuticals’ dental paste, Kourzeq, will be available for the treatment of oral lesions, including canker sores, via telehealth consultations.

The prescription triamcinolone acetonide paste is approved by the U.S. Food and Drug Administration and aims to help heal canker sores faster by reducing inflammation and relieving burning and pain.

Through a partnership between MidAmerica and BeyondMD, the product will only be available through telehealth visits. 

Page 1 of 7
Next Page